Simulations Plus

$525,000 Grant to Speed Commercialization of Advancements to Company’s Industry-Leading Molecular Property Prediction Software

Continued Growth – Revenues Up 12.7%, Cash Up 20.2%

Conference Call to be on Wednesday, April 15, at 4:15 PM EDT

Company Sets New Record for First Quarter: Revenues up 7.5% and Earnings Up Over 28%

Conference Call to be on Thursday, January 15, at 4:15 PM EST

New Version Further Improves Powerful Data Mining and Drug Design Capabilities

Earnings Up 17.7%, Shareholder Equity Up 29.4% Over Previous Fiscal Year

Up to $2.5 million over 12 months authorized by board of directors

Companies to Cooperate on Development of Advanced Ocular Delivery Simulation

Adds Property Prediction Software to Earlier GastroPlus(™) Licenses

Chemical Genomics Center Renews Five Licenses

Collaboration to Develop Drug-Drug Interaction Capability in GastroPlus™

"Conversa(™)" System Offers 12-inch Touch Tablet With Superior Voice Quality And Volume

Record revenues achieved in both business units

Conference Call to be on Tuesday, July 15, at 4:15 PM EDT

ADMET Predictor™ 3.0 Employs New Technology for Molecular Descriptors, All New Predictive Models